跳至主要内容
临床试验/NCT05365191
NCT05365191Unknown不适用

Development and Utilization of Indocyanine Green Fluorescence Near Infrared Zone II Lymphography in Breast Cancer Patients

National Taiwan University Hospital Hsin-Chu Branch2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年4月8日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
2
主要终点
Signal-to-background ratio (SBR)

研究概览

简要总结

This study aims for evaluating near infrared zone II imaging in sentinel lymph node mapping in breast cancer patients.

详细描述

Multi-wavelength fluorescence has been surveyed in various fields of surgery. However, it was still under investigation, and has not been matured for clinical use. This study will evaluate near infrared zone II spectrums for breast cancer patient undergoing sentinel lymph node mapping with near-infrared fluorescence navigation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

盲法说明

The patient will know they are going to accept near infrared zone II imaging during the sentinel lymph node biopsy procedure. They will not see the images and will not know the quality results.

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Breast cancer, adults

排除标准

  • Patient aged < 20 years old
  • Primary lesion without indication of sentinel lymph node biopsy in current guidelines (Low-risk ductal carcinoma in situ or metastatic breast cancer)
  • Patient who is allergic to primary tracers (including Tc99m and blue dye)
  • Patient who is allergic to indocyanine green

结局指标

主要结局

Signal-to-background ratio (SBR)

时间窗: through study completion, an average of 1 year

Evaluates the SBR of the near-infrared fluorescence between the retrieved sentinel lymph nodes and the background.

次要结局

  • Sentinel lymph nodes pathology(through study completion, an average of 1 year)
  • Penetration depth(through study completion, an average of 1 year)

研究者

发起方
National Taiwan University Hospital Hsin-Chu Branch
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

A Study Evaluating Near-infrared Zone II Imaging in... | 临床试验